bioRxivMolecular BiologyPreprint
Deletion of Lats 1 and 2 in mouse pancreatic acinar cells induces pancreatic fibrosis and inflammation
Ming GaoiD, Jun LiuiD, MICHAEL J. NIPPER, Francis E. SharkeyiD, Randy L. JohnsoniD, Howard C. CrawfordiD, Yidong CheniD, Pei WangiD
Abstract
ObjectiveThe Hippo signaling pathway is known for regulating proliferation, differentiation, organ size, and tumorigenesis. Large tumor suppressor kinase 1 and 2 (LATS1&2) are the core kinases of this pathway, whose functions in both the normal pancreas and pancreatic diseases are unclear. We studied the function of LATS1&2 specifically in pancreatic acinar cells of adult mice. DesignWe generated mice with adult pancreatic acinar cell-specific deletion of Lats1&2 genes by using CreER/LoxP. Pancreata were analyzed by histological examination, immunostaining, western blot, and RNA-sequencing. ResultsDeletion of Lats1&2 genes in adult pancreatic acinar cells resulted in rapid development of pancreatic inflammation and fibrosis. Loss of Lats1&2 did not directly induce acinar cell proliferation or apoptosis, but resulted in pancreatic stellate cell (PSC) activation followed by immune cell infiltration and acinar-to-ductal metaplasia. These effects were mediated by the Hippo downstream effectors YAP1/TAZ. By using neutralizing antibody to block CTGF, a YAP1/TAZ target, the inflammation and fibrosis were reduced. Our RNA-sequencing data identified upregulation of fibroinflammatory genes in Lats1&2 null pancreata, which may play important roles in stimulating PSC activation and promoting pancreatic fibrosis, as well as inflammation. ConclusionsDeletion of the Lats1&2 genes from adult acinar cells leads to the YAP1/TAZ dependent upregulation of a fibroinflammatory program. Our results emphasize the critical role of Lats1&2 in regulating PSC activation. Our findings identify new strategies for controlling pancreatic inflammation and fibrosis in diseases such as pancreatitis and pancreatic cancer.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploring the Role of YAP1 and TAZ in Pancreatic Acinar Cells and the Therapeutic Potential of VT-104 in Pancreatic Inflammation
Kevin M Lopez, Janice Deng, … Jun Liu·Journal of PancreatologyPeer-reviewed·Jan 16, 2024
- Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation
Yifan Wu, Kunhua Qin, … Pei Wang·eLifePeer-reviewed·Jun 17, 2024
- Epithelial FOXP3 Drives Pancreatic Fibrosis through O-glycosylated IL-6
Ruining Gong, Minghan Ren, … He Ren·bioRxiv·Nov 19, 2025
- Loss of Activating Transcription Factor 3 prevents KRAS-mediated pancreatic cancer
- BET inhibition rescues ciliogenesis and ameliorates pancreatitis-driven phenotypic changes in mice with Par3 loss.
M. A. Shields, A. E. Metropulos, … H. G. Munshi·bioRxiv·Sep 14, 2023
- NIK stabilization reprograms the pancreas toward chronic pancreatitis and pancreatic lipomatosis
Ziwei Du, Lilli Weber, … Thomas Wirth·bioRxiv·Oct 14, 2026